SKYSTAR BIO-PHARMACEUTICAL CO Accounts Receivable, Credit Loss Expense (Reversal)
SKYSTAR BIO-PHARMACEUTICAL CO reported Accounts Receivable, Credit Loss Expense (Reversal) of $1.93 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for the quarter ending 2014-09-30 was $1.13M, a 16.12% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for the quarter ending 2014-06-30 was $427.43K.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for the quarter ending 2014-03-31 was $366.22K, a 4.18% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for the quarter ending 2013-12-31 was -$931.43K.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for fiscal 2013 was $342.62K.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for fiscal 2012 was -$194.97K, a 327.87% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for fiscal 2011 was $85.56K.
- SKYSTAR BIO-PHARMACEUTICAL CO accounts receivable, credit loss expense (reversal) for fiscal 2010 was $0.00.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2014-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $1.56M derived: sum of 2 quarters · filed 2014-11-14 | $1.93M 10-Q · filed 2014-11-14 | $996.54K derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $427.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $793.64K 10-Q · filed 2014-08-14 | -$137.79K derived: sum of 3 quarters · filed 2014-08-14 | $839.10K derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $366.22K 10-Q · filed 2014-05-15 | -$565.22K derived: sum of 2 quarters · filed 2014-05-15 | $411.68K derived: sum of 3 quarters · filed 2014-11-14 | $357.31K derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | -$931.43K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $45.46K derived: sum of 2 quarters · filed 2014-11-14 | -$8.91K derived: sum of 3 quarters · filed 2014-11-14 | $342.62K 10-K · filed 2014-03-31 |
| 2013-09-30 | $976.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $922.52K derived: sum of 2 quarters · filed 2014-11-14 | $1.27M 10-Q · filed 2014-11-14 | $1.05M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | -$54.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $297.16K 10-Q · filed 2014-08-14 | $70.85K derived: sum of 3 quarters · filed 2014-08-14 | $947.00 derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $351.53K 10-Q · filed 2014-05-15 | $125.22K derived: sum of 2 quarters · filed 2014-05-15 | $55.32K derived: sum of 3 quarters · filed 2014-05-15 | $117.69K derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | -$226.31K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$296.22K derived: sum of 2 quarters · filed 2014-03-31 | -$233.84K derived: sum of 3 quarters · filed 2014-03-31 | -$194.97K 10-K · filed 2014-03-31 |
| 2012-09-30 | -$69.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$7.53K derived: sum of 2 quarters · filed 2013-11-14 | $31.34K 10-Q · filed 2013-11-14 | $116.90K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $62.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $101.25K 10-Q · filed 2013-08-14 | $186.81K derived: sum of 3 quarters · filed 2013-08-14 | $186.81K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $38.87K 10-Q · filed 2013-05-15 | $124.43K derived: sum of 2 quarters · filed 2013-05-15 | $124.43K derived: sum of 3 quarters · filed 2013-05-15 | $124.43K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $85.56K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $85.56K derived: sum of 2 quarters · filed 2013-04-01 | $85.56K derived: sum of 3 quarters · filed 2013-04-01 | $85.56K 10-K · filed 2013-04-01 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | $0.00 10-Q/A · filed 2012-09-13 | ||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | $0.00 10-K · filed 2012-03-30 | |||
| 2010-06-30 | $287.56K 10-Q/A · filed 2011-09-21 |